85 related articles for article (PubMed ID: 1461650)
21. Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines.
Glaise D; Ilyin GP; Loyer P; Cariou S; Bilodeau M; Lucas J; Puisieux A; Ozturk M; Guguen-Guillouzo C
Cell Growth Differ; 1998 Feb; 9(2):165-76. PubMed ID: 9486853
[TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
23. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
Kremenetskaya OS; Logacheva NP; Baryshnikov AY; Chumakov PM; Kopnin BP
Oncol Res; 1997; 9(4):155-66. PubMed ID: 9268986
[TBL] [Abstract][Full Text] [Related]
24. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
25. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
26. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
[TBL] [Abstract][Full Text] [Related]
27. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
28. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
[TBL] [Abstract][Full Text] [Related]
29. [Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors].
Riva-Lavieille C
Bull Cancer; 1994 Dec; 81 Suppl 2():105s-111s. PubMed ID: 7727855
[TBL] [Abstract][Full Text] [Related]
30. Terminal differentiation in a non-small-cell bronchopulmonary carcinoma correlates with increased expression of p53.
Liscia E; Riou D; Slavoshian S; Boesch S; Lebert V; Tomasoni C; Dabouis G; Biard JF; Roussakis C
Anticancer Res; 1996; 16(3A):1209-12. PubMed ID: 8702238
[TBL] [Abstract][Full Text] [Related]
31. Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors.
Quang CT; Pironin M; von Lindern M; Beug H; Ghysdael J
Oncogene; 1995 Oct; 11(7):1229-39. PubMed ID: 7478542
[TBL] [Abstract][Full Text] [Related]
32. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.
Kannan K; Kaminski N; Rechavi G; Jakob-Hirsch J; Amariglio N; Givol D
Oncogene; 2001 Jun; 20(26):3449-55. PubMed ID: 11423996
[TBL] [Abstract][Full Text] [Related]
33. p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation.
Casamassimi A; Miano MG; Porcellini A; De Vita G; de Nigris F; Zannini M; Di Lauro R; Russo T; Avvedimento VE; Fusco A
Cancer Res; 1998 Jul; 58(13):2888-94. PubMed ID: 9661907
[TBL] [Abstract][Full Text] [Related]
34. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
[TBL] [Abstract][Full Text] [Related]
35. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53.
Cory JG; He AW; Cory AH
Anticancer Res; 1996; 16(6B):3483-9. PubMed ID: 9042210
[TBL] [Abstract][Full Text] [Related]
36. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
37. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
[TBL] [Abstract][Full Text] [Related]
38. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein.
Weinberg WC; Azzoli CG; Chapman K; Levine AJ; Yuspa SH
Oncogene; 1995 Jun; 10(12):2271-9. PubMed ID: 7784075
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes.
Ceballos E; Muñoz-Alonso MJ; Berwanger B; Acosta JC; Hernández R; Krause M; Hartmann O; Eilers M; León J
Oncogene; 2005 Jun; 24(28):4559-71. PubMed ID: 15856024
[TBL] [Abstract][Full Text] [Related]
40. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]